NET1 promotes HCC growth and metastasis < em > in vitro < /em > and < em > in vivo < /em > via activating the Akt signaling pathway
In this study, we found that NET1 expression was upregulated in HCC, and that upregulated NET1 expression was closely associated with poor prognosis and some clinical characteristics in HCC patients. Whilst forced expression of NET1 in HCC cells was observed to significantly promote cell growth and metastasis in vitro and in vivo; downregulation of NET1 was shown to exhibit an opposite inhibitory effect. RNA-seq analysis and gene set enrichment analysis demonstrated that knockdown of NET1 significantly suppressed the level of Akt phosphorylation level and the expression of Akt downstream genes in HCC cells. Moreover, MK2206, a potent Akt inhibitor was shown to block the NET1-induced effects in HCC. Taken together, this study demonstrated that, through the Akt signaling pathway, NET1 plays an oncogenic role in HCC progression and metastasis. Hence, NET1 may potentially be used as a potential therapeutic target and prognostic marker of HCC.PMID:33839702 | DOI:10.18632/aging.202845
Source: Aging - Category: Biomedical Science Authors: Zhen-Hua Chen Qian-Zhi Ni Xiu-Ping Zhang Ning Ma Jing-Kai Feng Kang Wang Jing-Jing Li Dong Xie Xing-Yuan Ma Shu-Qun Cheng Source Type: research
More News: Biomedical Science | Brain | Brain Tumor | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Gastric (Stomach) Cancer | Gastroenterology | Genetics | Glioma | Hepatocellular Carcinoma | Liver Cancer | Neurology | Study